logo

For the Inventor, By the Inventor

Daejeon, South Korea

Bo Young Jeong

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pharmabcine Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Young Jeong. Retrieved from https://idiyas.com/inventor/bo-young-jeong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0


 

Average Co-Inventor Count = 25.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal2 out of 11 
 
Pharmabcine Inc.
 patents

Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
1. 10155817 - Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same (2018-12-18),
2. 9963512 - Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same (2018-05-08),

Title: Bo Young Jeong: Innovator in Dual-Target Antibody Development

Introduction

Bo Young Jeong is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of dual-target antibodies. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Bo Young Jeong holds 2 patents, with his latest inventions focusing on a dual-target antibody that targets VEGFR-2 and DLL4. This novel form of the dual-target antibody is designed to improve therapeutic outcomes in various medical applications. The patent details a gene encoding the antibody, a recombinant expression vector, and host cells transformed with this vector. Additionally, it outlines a method for producing the dual-target antibody and a pharmaceutical composition that includes the antibody.

Career Highlights

Throughout his career, Bo Young Jeong has been associated with Pharmabcine Inc., where he has played a crucial role in research and development. His work has not only contributed to the company's portfolio but has also advanced the field of antibody therapeutics.

Collaborations

Bo Young Jeong collaborates with talented individuals such as Joong Kyu Kim and Jin San Yoo, who contribute to the innovative projects at Pharmabcine Inc. Their teamwork fosters a creative environment that enhances the development of groundbreaking medical solutions.

Conclusion

Bo Young Jeong's contributions to the field of biotechnology, particularly through his dual-target antibody inventions, highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…